Leading Technical Translation Company in the US
Home/Industries/Medical Devices

Life sciences

Medical Device Translation Services

We translate IFUs, labeling, regulatory submissions, and quality system documents for US device manufacturers selling into the EU and beyond. Every deliverable follows an ISO 17100-compliant workflow with independent revision, built for content where a wrong word can trigger a nonconformity or harm a patient.

Get a Free Quote Itemized quote within one business hour
Regulatory affairs specialist reviewing translated medical device labeling
MDR language coverage

IFU and labeling translation for the EU member-state languages your notified body expects, delivered with certificates of accuracy for your technical file.

QMSR-ready documentation

Translated SOPs, validation protocols, and supplier records that hold up in audits under the FDA's ISO 13485-aligned quality regulation.

Recall-speed turnaround

Field safety notices and customer letters translated in parallel across markets, because corrective-action clocks do not pause for translation.

Medical device translation services for a regulated, multilingual market

American device manufacturers build for the world. The US medtech sector exports tens of billions of dollars of product a year, and for most companies the EU is the first and largest foreign market. It is also the most linguistically demanding one: a device cleared with a single English IFU for the US market may need that same IFU in twenty or more languages before it can ship across the EU. Our medical device translation services exist to close that gap without slowing your regulatory calendar. For 15 years we have translated instructions for use, labeling, submissions, and quality system content for manufacturers of Class I, II, and III devices, from single-use disposables to capital equipment.

Device translation is unlike ordinary technical work because the text itself is a regulated output. An IFU is part of the device under both FDA and EU definitions of labeling, which means a translation error is a product defect, with everything that implies for complaints, CAPAs, and liability. We structure our work accordingly: certified translators with life-science specialization, a second linguist performing independent revision on every file, terminology locked to your device master record, and documentation of the process itself, because your auditors will ask how translations were controlled, not just whether they exist.

From 21 CFR 820 to the QMSR: what the 2024 shift means for translated documents

In February 2024, the FDA published the Quality Management System Regulation, replacing the Quality System Regulation at 21 CFR 820 with a framework that incorporates ISO 13485:2016 by reference, with a compliance date of February 2, 2026. For US manufacturers this is mostly good news: one quality system can now serve FDA inspections and international registrations. But harmonization has a documentary consequence. Companies that maintained separate US and international quality documentation are consolidating into single global document sets, and those sets must be usable at every site, including plants in Mexico, Costa Rica, and Europe where English is not the working language.

That is where we come in. We translate quality manuals, procedures, and work instructions so that the operator in Tijuana and the auditor in Minneapolis read the same requirement. Our SOP translation work in this sector covers everything from incoming inspection procedures to complaint-handling workflows, and it is built around a controlled bilingual glossary so that "shall," "should," and "may" keep their exact regulatory weight in every language. We apply the same discipline when translating validation protocols, where an IQ/OQ/PQ document with a shifted acceptance criterion is worse than no translation at all.

EU MDR 2017/745: the language rules that drive your translation budget

Regulation (EU) 2017/745 raised the stakes on language. Article 10(11) requires that the information supplied with the device be in an official Union language determined by the member state where the device is made available, and Annex I Chapter III spells out content requirements for IFUs and labels. In practice, each of the 27 member states decides which languages it accepts, and most require their own. Some allow English for professional-use devices; almost none do for devices used by laypersons. The result: a manufacturer selling EU-wide plans for up to 24 official languages, phased by market entry.

Language requirements differ enough by country that we advise mapping them before quoting. A sample of how member states treat professional-use devices:

MarketIFU language for lay usersProfessional-use devices
GermanyGerman requiredGerman expected; English rarely accepted
FranceFrench requiredFrench required in nearly all cases
NetherlandsDutch requiredEnglish often accepted with conditions
SpainSpanish requiredSpanish required
ItalyItalian requiredItalian required

We help clients sequence this: launch languages first, second-wave markets as distribution expands, one translation memory carrying shared content across all of them. Because MDR technical documentation must include labeling and IFUs in the languages of intended markets, our deliverables for regulatory submission translation arrive audit-ready, with certificates of accuracy your regulatory affairs team can file directly in the technical file reviewed by your notified body.

IFUs, labels, and the symbols that reduce your word count

The IFU is the heaviest translation object in most device companies, and the smartest manufacturers engineer it for multilingual efficiency before translation starts. ISO 15223-1:2021 defines symbols for medical device labeling that regulators accept without accompanying text, from "single use only" to "manufacturer" and "use-by date." Every requirement you express with a validated symbol is a phrase you never pay to translate into 24 languages. We routinely review label artwork with clients and flag text that a symbol could replace, then translate what genuinely must remain as words.

What remains still demands care. Warnings and contraindications carry legal force and must keep their exact scope: a French warning that reads slightly broader than the English original can create off-label exposure, while one that reads narrower can miss a hazard. Our teams working on IFU and user manual translation follow the source sentence by sentence for safety content, no elegant paraphrasing, and validate readability for lay audiences where the device requires it. The same goes for translating packaging and labels, where space constraints meet UDI requirements: the Unique Device Identification data itself stays untranslated by design, but the human-readable text around it must fit multilingual panels that were often designed for one language.

A symbol is worth 24 translations. On a recent labeling overhaul for an orthopedic instrument line, replacing eleven text statements with ISO 15223-1 symbols cut the translatable label text by 38%, saving the client roughly a third of its recurring labeling translation spend across every EU market at once.

Recalls, field safety corrective actions, and CAPA documentation

Nothing tests a translation partner like a recall. When a field safety corrective action goes out, the field safety notice must reach users in every affected market, in their language, on the competent authority's clock, and national authorities in Europe expect notices in their official language as a matter of course. We keep recall workflows pre-built for device clients: a standing team per language, an agreed template structure, and a same-week cycle for notices, customer letters, and updated IFU inserts across all markets in parallel rather than in sequence.

The documentation trail behind the recall gets translated too. Complaint records arriving from foreign distributors, CAPA investigations involving a European supplier, correspondence with competent authorities: all of it feeds your quality system and, eventually, your next FDA inspection. Translated consistently, it shows a controlled process. Translated ad hoc by whoever was available, it shows exactly the kind of gap investigators write up.

Terminology pitfalls specific to device content

Device language is full of terms of art that punish casual translation. "Intended use" and "indications for use" are distinct regulatory concepts in FDA practice, and collapsing them into one phrase in German or French muddies a submission. "Serious injury," "malfunction," and "adverse event" trigger different reporting obligations and must map onto the corresponding terms in EU vigilance vocabulary, not onto whatever a general translator finds natural. "Reprocessing" means one thing for a hospital sterilization department and another in FDA's single-use device reuse framework. Even "label" versus "labeling" carries regulatory weight in English that other languages express differently.

We manage this with device-specific termbases seeded from MDR text, FDA guidance, and each client's own regulatory filings, then reviewed by the client's regulatory affairs staff before volume translation begins. It is slower for the first week and faster forever after. Our linguists in this sector are certified translators who work in life sciences daily; as members of the American Translators Association and GALA, we can also provide the translator qualification records that some notified bodies now request as part of supplier evaluation.

The languages that matter for US device makers, and why

German comes first for most of our device clients: Germany is Europe's largest device market, home to demanding university hospital buyers and to notified bodies that read technical files in German. Our German technical translation team handles both directions, translating your IFUs into German and your German suppliers' certificates into English. French follows, covering France, Belgium, and Luxembourg within the EU plus Canadian bilingual labeling under Health Canada rules, which require French for devices sold in Canada. For details on that pair, see this page.

Spanish does double duty: it is required for Spain under MDR and it serves the large Spanish-speaking populations of US hospitals and home-use patients, where FDA human factors thinking increasingly expects labeling comprehension across the real user population. Italian rounds out the core four, both for the Italian market and because Italy hosts a dense contract-manufacturing base whose quality records US manufacturers must read. Beyond these, we schedule second-wave EU languages, Portuguese, Dutch, Nordic and Central European languages, as distribution agreements come online, reusing the shared translation memory to keep per-language cost falling with each addition.

eIFUs and post-market surveillance content

Electronic instructions for use are changing the economics of device labeling. Under Implementing Regulation (EU) 2021/2226, manufacturers of certain professional-use devices may supply IFUs electronically instead of on paper, provided a paper copy remains available on request. For translation, this cuts print and kitting costs but not language obligations: the eIFU portal still has to serve each market in its accepted language, and the portal interface itself becomes a small localization project of its own. We translate both layers, the IFU content and the site chrome around it, and we keep version histories aligned so that the German PDF a clinician downloads today matches revision F, not revision D.

Post-market surveillance generates a quieter but steady stream of multilingual work. PMS plans and reports under MDR Articles 83 through 86 draw on complaint data, distributor feedback, and literature from every market where the device sells, and much of that raw material arrives in French, Italian, or German. We translate inbound field reports into English for your quality team and outbound PSUR-related correspondence when a competent authority asks questions. Trend signals hide in language: a complaint described as "device separated" by one distributor and "component detached" by another may be the same failure mode, and consistent translation is what lets your surveillance system count them together.

Usability engineering files under IEC 62366-1 follow the same pattern. If you run formative or summative studies with non-English-speaking participants, the moderator guides, task instructions, and questionnaire responses all cross languages twice, once going out and once coming back. We handle both legs with the same terminology base as the IFU, since a usability study that tests different wording than the final labeling proves less than it should.

How a device translation project runs at Techniwords

A typical engagement: a Midwest manufacturer of surgical instrument trays came to us after its notified body flagged inconsistent terminology across its French and Italian IFUs, two documents translated years apart by different vendors. We rebuilt the termbase from the current technical file, retranslated the divergent sections, and delivered a reconciliation memo the client filed with its response. The finding closed at the next surveillance audit. Since then the client sends every labeling change through us in all four of its EU languages simultaneously, which is cheaper and calmer than translating market by market.

Every project follows the same controlled path from our Texas base: scope and termbase alignment, translation by a life-science specialist, independent revision by a second qualified linguist under our ISO 17100-compliant process, in-context review of formatted labeling artwork, and delivery with a signed certificate of accuracy. We hold formatting to your document control standards so the translated IFU carries the correct document number, revision, and effective date, ready for your eQMS. And we keep your translation memory current across revisions, because in this industry, revision C will arrive. It always does. You can see how this connects to neighboring sectors on our industries hub.

Medical device translation: frequently asked questions

Which languages does EU MDR actually require for our device?

It depends on where you sell and who uses the device. Each EU member state sets its own language requirements under Article 10(11) of MDR 2017/745. Devices used by laypersons almost always require the national language; some states accept English IFUs for professional-use devices, often with conditions. A manufacturer selling EU-wide should plan for up to 24 official languages, phased by market entry. We map the exact requirements for your target markets and device class before quoting, so you translate what is required and nothing more.

Can ISO 15223 symbols reduce how much we need to translate?

Significantly. ISO 15223-1:2021 defines label symbols that EU and FDA regulators accept without accompanying text, covering statements like single use, sterile, manufacturer, and use-by date. Every statement you replace with a validated symbol is text you no longer translate into every market language. We review label artwork with clients before translation, flag candidates for symbol substitution, and translate only what must remain as words. On one orthopedic labeling project this cut translatable label text by 38%.

How does the FDA's new QMSR affect translated documentation?

The QMSR, published in February 2024 with a compliance date of February 2, 2026, incorporates ISO 13485:2016 into FDA regulation, replacing the old 21 CFR 820 framework. Most manufacturers are consolidating separate US and international quality documents into one global set. That set must work at every site, so SOPs, work instructions, and training records increasingly need controlled translations for plants in Mexico, Costa Rica, and Europe. We translate quality system documents against a locked glossary so requirements keep identical force in every language.

How fast can you translate a field safety notice for a recall?

For established clients we run recall workflows on a same-week cycle: field safety notices, customer letters, and updated IFU inserts translated in parallel across all affected markets rather than one after another. We keep a standing team per language and pre-agreed templates, because competent authorities expect notices in their official language on the corrective-action clock. For new clients in an active recall we mobilize within 24 hours; send us the notice and the affected market list and we will confirm a schedule the same day.

Does our device class change the translation requirements?

Class changes the stakes and the paperwork more than the language rules. Language requirements under MDR follow the user (layperson versus professional) and the member state, not the class directly. But higher-class devices carry heavier technical documentation, more notified body scrutiny, and more content overall: clinical evaluations, risk documentation, and post-market surveillance reports that may need translation during audits or submissions. A Class III technical file simply has more words in more documents, so translation planning starts earlier.

Do you provide certificates of accuracy for our technical file?

Yes. Every regulatory deliverable ships with a signed certificate of accuracy identifying the source and target documents, the language pair, and the process applied, including independent revision by a second qualified linguist under our ISO 17100-compliant workflow. Notified bodies and FDA investigators do not usually ask to see the certificate, but they do ask how translations are controlled, and the certificate plus our process documentation answers that question cleanly inside your supplier controls.

Get your IFUs audit-ready in every market language

Send us your IFU, label artwork, or submission package and tell us your target markets. We will return an itemized quote with a language map for your EU launch sequence, certificates of accuracy included.

Get a Free Quote

info@techniwords.us · (346) 296-6516

Multilingual instructions for use packaged with a medical device